Preview

Acta Biomedica Scientifica

Advanced search

Indicators of immunocompetent blood cells of experimental animals immunized against plague on the background of immunomodulation

https://doi.org/10.29413/ABS.2025-10.5.10

Abstract

The strategy of specific prophylaxis of plague for epidemic indications accepted in the Russian Federation, while having positive experience, needs to be improved. The solution to one of the problems is the use of vaccines together with adjuvants. The ability of the selenium-containing preparation 974zh to increase the immunogenicity of live plague vaccine was demonstrated.
The aim of the work. To evaluate the subpopulation composition of blood cells in animals immunized by Y. pestis EV on the background of immunomodulation.
Materials and methods. In the study we used 100 white mice. Blood served as a material for the study. The phenotype of lymphocytes was determined on a flow cytofluorimeter using antibodies to markers CD45, CD44, CD3, CD19, CD4, CD8, CD25, CD62L, I-A/I-E (MHC II).
Results. Evaluation of cellular immunity revealed a statistically significant increase in monocytes on day 7 and a decrease in lymphocytes on day 3 in mice immunized with Y. pestis EV at doses of 103 CFU and 104 CFU in combination with 974zh. When co-injected with Y. pestis EV (103 CFU) and 974zh, unlike Y. pestis EV at different doses, no decrease in CD3+CD4+CD8-CD25+ cells was detected.
Conclusion. Thus, the adjuvant property of 974zh has been established, contributing to an increase in the immunogenic properties of the Y. pestis EV vaccine strain, regardless of the dose. The use of Y. pestis EV at a dose of 103 CFU to reduce the bacterial load is appropriate.

About the Authors

A. B. Pyatidesyatnikova
Irkutsk Antiplague Research Institute of Siberia and Far East of Rospotrebnadzor
Russian Federation

Anna B. Pyatidesyatnikova – Junior Research of Pathophysiological Laboratory 

Trilissera str., 78, Irkutsk 664047, Russian Federation 



V. I. Dubrovina
Irkutsk Antiplague Research Institute of Siberia and Far East of Rospotrebnadzor
Russian Federation

Valentina I. Dubrovina – Dr. Sc. (Biol.), Head of Pathophysiological Laboratory

Trilissera str., 78, Irkutsk 664047, Russian Federation 



K. M. Korytov
Irkutsk Antiplague Research Institute of Siberia and Far East of Rospotrebnadzor
Russian Federation

Konstantin M. Korytov – Research Officer, Pathophysiological Laboratory

Trilissera str., 78, Irkutsk 664047, Russian Federation 



N. O. Kiseleva
Irkutsk Antiplague Research Institute of Siberia and Far East of Rospotrebnadzor
Russian Federation

Natalya O. Kiseleva – Junior Research of Pathophysiological Laboratory

Trilissera str., 78, Irkutsk 664047, Russian Federation 



S. V. Balakhonov
Irkutsk Antiplague Research Institute of Siberia and Far East of Rospotrebnadzor
Russian Federation

Sergey V. Balakhonov – Dr. Sc. (Med.), Professor, Director 

Trilissera str., 78, Irkutsk 664047, Russian Federation 



References

1. Popova AYu, Bugorkova SA, Popov NV, Matrosov AN, Klyueva SN, Eroshenko GA, et. al. Specific prevention of the plague: condition. Saratov: Amirite; 2021 (In Russ.).

2. Bugorkova SA, Klyueva SN, Kudryavtseva OM, Toporkov VP, Shchukovskaya TN, Kravtsov AL, et. al. Immunological monitoring of vaccinated against plague in the Caspian sandy natural hearth to assess and manage public health risks. Risk assessment in epidemiology. 2020; 4: 121-127. (In Russ.). doi: 10.21668/health.risk/2020.4.14

3. Mikshis NI, Kutyrev VV. Current State of the Problem of Vaccine Development for Specific Prophylaxis of Plague. Problems of Particularly Dangerous Infections. 2019; (1): 50-63. (In Russ.). doi: 10.21055/0370-1069-2019-1-50-63

4. Verma SK, Mahajan P, Singh NK, Gupta A, Aggarwal R, Rappuoli R, et. al. New-age vaccine adjuvants, their development, and future perspective. Front. Immunol. 2023; 14: 1043109. doi: 10.3389/fimmu.2023.1043109

5. Andreev YuYu, Toptygina AP. Adjuvants and immunomodulators in vaccines. Immunology. 2021; 42(6): 720-729. (In Russ.). doi: 10.33029/0206-4952-2021-42-6-720-729

6. Potapov VA, Musalov MV, Musalova MV, Amosova SV. Recent advances in organochalcogen synthesis based on reactions of chalcogen halides with alkynes and alkenes. Curr. Organ. Chem. 2016; 20(2): 136-145. doi: 10.2174/1385272819666150810222454

7. Yur’eva OV, Dubrovina VI, Potapov VA, Musalov MV, Starovoitova TP, Ivanova TA, et. al. Immunotropic Properties of an Experimental Synthetic Selenium-Organic Compound. Bull Exp Biol Med. 2020; 169(1): 40-42. doi: 10.1007/s10517-020-04819-4

8. Dubrovina VI, Yur’eva OV, Starovoitova TP, Pyatidesyatnikova AB, Ivanova TA, Grigor’evykh AV, et. al. The Influence of the Synthetic Organoselenium Preparation 974zh on the Immunogenic Activity of Yersinia pestis EV Vaccine Strain NIIEG. Bull Exp Biol Med. 2023; 175(4): 473-477. (In Russ.).

9. Kudryavtseva OM, Goncharova AYu, Kozhevnikov VA, Bugorkova SA. A comprehensive approach to assessing and predicting the immune response to vaccination in people vaccinated against plague. Problems of Particularly Dangerous Infections. 2024; (3): 118-125. (In Russ.). doi: 10.21055/0370-1069-2024-3-118-125


Review

For citations:


Pyatidesyatnikova A.B., Dubrovina V.I., Korytov K.M., Kiseleva N.O., Balakhonov S.V. Indicators of immunocompetent blood cells of experimental animals immunized against plague on the background of immunomodulation. Acta Biomedica Scientifica. 2025;10(5):93-99. (In Russ.) https://doi.org/10.29413/ABS.2025-10.5.10

Views: 282


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2541-9420 (Print)
ISSN 2587-9596 (Online)